Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing.

Howes MR, Perry NSL, Vásquez-Londoño C, Perry EK.

Br J Pharmacol. 2019 Oct 25. doi: 10.1111/bph.14898. [Epub ahead of print] Review.

PMID:
31650528
2.

The transcription factors ActR and SoxR differentially affect the phenazine tolerance of Agrobacterium tumefaciens.

Perry EK, Newman DK.

Mol Microbiol. 2019 Jul;112(1):199-218. doi: 10.1111/mmi.14263. Epub 2019 May 3.

PMID:
31001852
3.

A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age.

Perry NSL, Menzies R, Hodgson F, Wedgewood P, Howes MR, Brooker HJ, Wesnes KA, Perry EK.

Phytomedicine. 2018 Jan 15;39:42-48. doi: 10.1016/j.phymed.2017.08.015. Epub 2017 Aug 18.

PMID:
29433682
4.

The Low-Diversity Fecal Microbiota of the Critically Endangered Kākāpō Is Robust to Anthropogenic Dietary and Geographic Influences.

Perry EK, Digby A, Taylor MW.

Front Microbiol. 2017 Oct 20;8:2033. doi: 10.3389/fmicb.2017.02033. eCollection 2017.

5.

Sequential Release of Multiple Drugs from Flexible Drug Delivery Films.

Jennings CL, Perry EK, Dziubla TD, Puleo DA.

Int J Polym Mater. 2017;66(11):569-576. doi: 10.1080/00914037.2016.1252352. Epub 2017 Jan 4.

6.

Activating and Attenuating the Amicoumacin Antibiotics.

Park HB, Perez CE, Perry EK, Crawford JM.

Molecules. 2016 Jun 24;21(7). pii: E824. doi: 10.3390/molecules21070824.

7.

Nutrient Distribution and Absorption in the Colonial Hydroid Podocoryna carnea Is Sequentially Diffusive and Directional.

Buss LW, Anderson CP, Perry EK, Buss ED, Bolton EW.

PLoS One. 2015 Sep 11;10(9):e0136814. doi: 10.1371/journal.pone.0136814. eCollection 2015.

8.

Stage-specific changes in neurogenic and glial markers in Alzheimer's disease.

Ekonomou A, Savva GM, Brayne C, Forster G, Francis PT, Johnson M, Perry EK, Attems J, Somani A, Minger SL, Ballard CG; Medical Research Council Cognitive Function and Ageing Neuropathology Study.

Biol Psychiatry. 2015 Apr 15;77(8):711-9. doi: 10.1016/j.biopsych.2014.05.021. Epub 2014 Jun 9.

PMID:
25022604
9.

Dynamin protein in stroke and vascular dementia.

Mulugeta E, Vallortigara J, Francis PT, Hye A, Kalaria RN, Perry EK, Lovestone S, Ballard CG.

Neurosci Lett. 2014 Mar 20;563:118-22. doi: 10.1016/j.neulet.2014.01.045. Epub 2014 Jan 31.

PMID:
24486840
10.

Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies.

Mukaetova-Ladinska EB, Andras A, Milne J, Abdel-All Z, Borr I, Jaros E, Perry RH, Honer WG, Cleghorn A, Doherty J, McIntosh G, Perry EK, Kalaria RN, McKeith IG.

J Neuropathol Exp Neurol. 2013 Jan;72(1):53-60. doi: 10.1097/NEN.0b013e31827c5710.

PMID:
23242284
11.

Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology.

Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J.

Neurobiol Dis. 2012 Aug;47(2):155-62. doi: 10.1016/j.nbd.2012.03.033. Epub 2012 Apr 5.

12.

Increased neural progenitors in individuals with cerebral small vessel disease.

Ekonomou A, Johnson M, Perry RH, Perry EK, Kalaria RN, Minger SL, Ballard CG.

Neuropathol Appl Neurobiol. 2012 Jun;38(4):344-53. doi: 10.1111/j.1365-2990.2011.01224.x.

PMID:
21988073
13.

The effect of drug treatment on neurogenesis in Parkinson's disease.

O'Sullivan SS, Johnson M, Williams DR, Revesz T, Holton JL, Lees AJ, Perry EK.

Mov Disord. 2011 Jan;26(1):45-50. doi: 10.1002/mds.23340. Epub 2010 Nov 16.

PMID:
21322018
14.

Cerebrospinal fluid biomarkers for dementia with lewy bodies.

Mukaetova-Ladinska EB, Monteith R, Perry EK.

Int J Alzheimers Dis. 2010 Oct 17;2010:536538. doi: 10.4061/2010/536538.

15.

Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies.

Johnson M, Ekonomou A, Hobbs C, Ballard CG, Perry RH, Perry EK.

Hippocampus. 2011 Oct;21(10):1126-36. doi: 10.1002/hipo.20826. Epub 2010 Jul 21.

PMID:
20665591
16.

Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies.

Bernstein HG, Johnson M, Perry RH, LeBeau FE, Dobrowolny H, Bogerts B, Perry EK.

Neuropathology. 2011 Feb;31(1):1-10. doi: 10.1111/j.1440-1789.2010.01117.x.

PMID:
20487308
17.

Increased neural progenitors in vascular dementia.

Ekonomou A, Ballard CG, Pathmanaban ON, Perry RH, Perry EK, Kalaria RN, Minger SL.

Neurobiol Aging. 2011 Dec;32(12):2152-61. doi: 10.1016/j.neurobiolaging.2010.01.007. Epub 2010 Feb 5.

PMID:
20138403
18.

Nicotinic 123I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in Alzheimer's disease and dementia with Lewy bodies.

Colloby SJ, Perry EK, Pakrasi S, Pimlott SL, Wyper DJ, McKeith IG, Williams ED, O'Brien JT.

Am J Geriatr Psychiatry. 2010 Jan;18(1):86-90. doi: 10.1097/JGP.0b013e3181b972aa.

PMID:
20094022
19.

Alterations in nicotinic α4β2 receptor binding in vascular dementia using ¹²³I-5IA-85380 SPECT: comparison with regional cerebral blood flow.

Colloby SJ, Firbank MJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, McKeith IG, Williams ED, O'Brien JT.

Neurobiol Aging. 2011 Feb;32(2):293-301. doi: 10.1016/j.neurobiolaging.2009.02.005. Epub 2009 Mar 9.

PMID:
19269714
20.

Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease.

Chalmers KA, Wilcock GK, Vinters HV, Perry EK, Perry R, Ballard CG, Love S.

J Neurol. 2009 May;256(5):717-20. doi: 10.1007/s00415-009-5000-2. Epub 2009 Feb 25.

21.

Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels.

Huang L, Abuhamdah S, Howes MJ, Dixon CL, Elliot MS, Ballard C, Holmes C, Burns A, Perry EK, Francis PT, Lees G, Chazot PL.

J Pharm Pharmacol. 2008 Nov;60(11):1515-22. doi: 10.1211/jpp/60.11.0013. Erratum in: J Pharm Pharmacol. 2009 Feb;61(2):267. Dixon, Christine L [added].

PMID:
18957173
22.

Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia.

Sharp SI, Ballard CG, Ziabreva I, Piggott MA, Perry RH, Perry EK, Aarsland D, Ehrt U, Larsen JP, Francis PT.

Dement Geriatr Cogn Disord. 2008;26(4):330-8. doi: 10.1159/000161058. Epub 2008 Oct 8.

PMID:
18841018
23.

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P; World Federation of Neurology Dementia Research Group.

Lancet Neurol. 2008 Sep;7(9):812-26. doi: 10.1016/S1474-4422(08)70169-8. Epub 2008 Jul 28. Review. Erratum in: Lancet Neurol. 2008 Oct;7(10):867.

24.

Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.

Tasker A, Ballard CG, Joachim C, Warden DR, Okello EJ, Perry RH, Khan N, Smith AD, Lehmann DJ, Perry EK.

Neurosci Lett. 2008 Sep 19;442(3):297-9. doi: 10.1016/j.neulet.2008.07.023. Epub 2008 Jul 12.

PMID:
18640242
25.

An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers.

Scholey AB, Tildesley NT, Ballard CG, Wesnes KA, Tasker A, Perry EK, Kennedy DO.

Psychopharmacology (Berl). 2008 May;198(1):127-39. doi: 10.1007/s00213-008-1101-3. Epub 2008 Mar 19.

PMID:
18350281
26.

Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations.

O'Brien JT, Colloby SJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, McKeith IG, Williams ED.

Neuroimage. 2008 Apr 15;40(3):1056-63. doi: 10.1016/j.neuroimage.2008.01.010. Epub 2008 Jan 19.

PMID:
18295510
27.

Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channels.

Abuhamdah S, Huang L, Elliott MS, Howes MJ, Ballard C, Holmes C, Burns A, Perry EK, Francis PT, Lees G, Chazot PL.

J Pharm Pharmacol. 2008 Mar;60(3):377-84. doi: 10.1211/jpp.60.3.0014.

PMID:
18284819
28.

Intact coupling of M1 receptors and preserved M2 and M4 receptors in the cortex in progressive supranuclear palsy: contrast with other dementias.

Warren NM, Piggott MA, Lees AJ, Perry EK, Burn DJ.

J Chem Neuroanat. 2008 May;35(3):268-74. doi: 10.1016/j.jchemneu.2008.01.001. Epub 2008 Jan 16.

PMID:
18282687
29.
30.

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.

Piggott MA, Ballard CG, Rowan E, Holmes C, McKeith IG, Jaros E, Perry RH, Perry EK.

Synapse. 2007 Nov;61(11):903-11.

PMID:
17663455
31.

Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.

Ballard CG, Chalmers KA, Todd C, McKeith IG, O'Brien JT, Wilcock G, Love S, Perry EK.

Neurology. 2007 May 15;68(20):1726-9.

PMID:
17502555
32.

Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT.

Pakrasi S, Colloby SJ, Firbank MJ, Perry EK, Wyper DJ, Owens J, McKeith IG, Williams ED, O'Brien JT.

J Neurol. 2007 Jul;254(7):907-13. Epub 2007 Mar 14.

PMID:
17361343
33.

Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography.

O'Brien JT, Colloby SJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, McKeith IG, Williams ED.

J Neurol Neurosurg Psychiatry. 2007 Apr;78(4):356-62. Epub 2006 Nov 29.

34.

In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.

Colloby SJ, Pakrasi S, Firbank MJ, Perry EK, Piggott MA, Owens J, Wyper DJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT.

Neuroimage. 2006 Nov 1;33(2):423-9. Epub 2006 Sep 7.

PMID:
16959499
35.

Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.

Piggott MA, Ballard CG, Dickinson HO, McKeith IG, Perry RH, Perry EK.

Int J Neuropsychopharmacol. 2007 Apr;10(2):231-44. Epub 2006 Feb 1.

PMID:
16448581
36.

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M; Consortium on DLB.

Neurology. 2005 Dec 27;65(12):1863-72. Epub 2005 Oct 19. Review. Erratum in: Neurology. 2005 Dec 27;65(12):1992.

PMID:
16237129
37.

Neurotransmitter abnormalities in vascular dementia.

Court JA, Perry EK.

Int Psychogeriatr. 2003;15 Suppl 1:81-7.

PMID:
16191222
38.

Attenuation of Abeta deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking.

Court JA, Johnson M, Religa D, Keverne J, Kalaria R, Jaros E, McKeith IG, Perry R, Naslund J, Perry EK.

Neuropathol Appl Neurobiol. 2005 Oct;31(5):522-35.

PMID:
16150123
39.

Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies.

Ballard CG, Perry RH, McKeith IG, Perry EK.

Int J Geriatr Psychiatry. 2005 Sep;20(9):872-5.

PMID:
16116579
40.

Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus.

Ray MA, Graham AJ, Lee M, Perry RH, Court JA, Perry EK.

Neurobiol Dis. 2005 Aug;19(3):366-77.

PMID:
16023579
41.

Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies.

Teaktong T, Piggott MA, Mckeith IG, Perry RH, Ballard CG, Perry EK.

Behav Brain Res. 2005 Jun 20;161(2):299-305. Epub 2005 Mar 21.

PMID:
15922057
42.

Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism.

Ziabreva I, Ballard CG, Aarsland D, Larsen JP, McKeith IG, Perry RH, Perry EK.

Neurobiol Aging. 2006 Mar;27(3):433-8.

PMID:
15913843
43.

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, Burn D, Ballard CG.

J Clin Psychiatry. 2005 May;66(5):633-7.

PMID:
15889951
44.

Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment.

Tasker A, Perry EK, Ballard CG.

Expert Rev Neurother. 2005 Jan;5(1):101-6.

PMID:
15853480
45.

Cholinergic systems in progressive supranuclear palsy.

Warren NM, Piggott MA, Perry EK, Burn DJ.

Brain. 2005 Feb;128(Pt 2):239-49. Epub 2005 Jan 13. Review.

PMID:
15649952
46.

Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus.

Bohr IJ, Ray MA, McIntosh JM, Chalon S, Guilloteau D, McKeith IG, Perry RH, Clementi F, Perry EK, Court JA, Piggott MA.

Exp Neurol. 2005 Feb;191(2):292-300.

PMID:
15649484
47.

Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers.

Tildesley NT, Kennedy DO, Perry EK, Ballard CG, Wesnes KA, Scholey AB.

Physiol Behav. 2005 Jan 17;83(5):699-709.

PMID:
15639154
48.
49.

Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.

Teaktong T, Graham AJ, Court JA, Perry RH, Jaros E, Johnson M, Hall R, Perry EK.

J Neurol Sci. 2004 Oct 15;225(1-2):39-49.

PMID:
15465084
50.

Selective changes in nicotinic acetylcholine receptor subtypes related to tobacco smoking: an immunohistochemical study.

Teaktong T, Graham AJ, Johnson M, Court JA, Perry EK.

Neuropathol Appl Neurobiol. 2004 Jun;30(3):243-54.

PMID:
15175078

Supplemental Content

Loading ...
Support Center